Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Tachyarrhythmia

Tundra lists 3 Tachyarrhythmia clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06382207

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.

Gender: All

Ages: Any - 1 Year

Updated: 2026-03-12

1 state

Tachyarrhythmia
NOT YET RECRUITING

NCT07360158

BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs

The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features. The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky). The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.

Gender: All

Ages: 18 Years - 99 Years

Updated: 2026-03-06

Tachyarrhythmia
Heart Failure
ENROLLING BY INVITATION

NCT07005232

Lead Evaluation for Defibrillation and Reliability Post Approval Study

Medtronic is sponsoring the LEADR PAS to provide continuing evaluation and periodic reporting of safety and effectiveness of the OmniaSecure™ defibrillation lead following commercial release. The LEADR PAS is conducted within Medtronic's Product Surveillance Registry Platform (NCT01524276).

Gender: All

Updated: 2026-02-03

19 states

Tachyarrhythmia